Catalent expects IPO to be priced between $19-$22/shr-Reuters

(Reuters) – Catalent Inc, controlled by Blackstone Group LP, said it expects its initial public offering to be priced between $19 and $22 per share, valuing the health technology company at about $2.57 billion at the top end.

Catalent’s IPO of 42.5 million shares is expected to raise about $935 million at the top end of the expected price range.

The company provides advanced delivery technologies for drugs, biologics and consumer health products.

Leave a Reply

PE HUB Community

Join the 12518 members of PE HUB to make connections, share your opinion, and follow your favorite authors.

Join the Community

Look Who’s Tweeting

PE HUB News Briefs

RSS Feed Widget

VCJ Headlines (subscribers only)

RSS Feed Widget

Buyouts Headlines (subscribers only)

RSS Feed Widget